Cargando…

Cefiderocol Efficacy in a Real-Life Setting: Single-Centre Retrospective Study

The current carbapenem-resistant gram-negative bacteria (CR-GN) treatment guidelines lack strong evidence about cefiderocol (CFD) efficacy against CR-GN, especially CRAB. The study’s purpose is to evaluate the effectiveness of CFD in a real-life setting. We made a single-center retrospective study o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palermo, Gabriele, Medaglia, Alice Annalisa, Pipitò, Luca, Rubino, Raffaella, Costantini, Manuela, Accomando, Salvatore, Giammanco, Giovanni Maurizio, Cascio, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135318/ https://www.ncbi.nlm.nih.gov/pubmed/37107108 http://dx.doi.org/10.3390/antibiotics12040746

Ejemplares similares

Multisystem Inflammatory Syndrome: A Case in an Adult With Controlled Lymphoma and a Persistent SARS-CoV-2 Infection
por: Pipitò, Luca, et al.
Publicado: (2023)

Ceftazidime-Avibactam as Osteomyelitis Therapy: A Miniseries and Review of the Literature
por: Mancuso, Alessandro, et al.
Publicado: (2023)

Clostridioides difficile Infection in an Italian Tertiary Care University Hospital: A Retrospective Analysis
por: Medaglia, Alice Annalisa, et al.
Publicado: (2023)

A case of syphilis associated with immune reconstitution inflammatory syndrome and review of the literature
por: Pipitò, Luca, et al.
Publicado: (2023)

Hemophagocytic lymphohistiocytosis secondary to histoplasmosis: A case report in a patient with AIDS and recent SARS-CoV-2 infection and minireview
por: Pipitò, Luca, et al.
Publicado: (2023)

An emergent infectious disease: Clostridioides difficile infection hospitalizations, 10-year trend in Sicily
por: Medaglia, Alice Annalisa, et al.
Publicado: (2021)

Correction to: An emergent infectious disease: Clostridioides difficile infection hospitalizations, 10-year trend in Sicily
por: Medaglia, Alice Annalisa, et al.
Publicado: (2021)

Monkeypox virus infection and creatine phosphokinase increase: A case from Italy
por: Pipitò, Luca, et al.
Publicado: (2022)

Genital pustules, fever, lymphadenopathy in a heterosexual couple
por: Pipitò, Luca, et al.
Publicado: (2022)

Kawasaki disease recurrence in the COVID-19 era: a systematic review of the literature
por: Medaglia, Alice Annalisa, et al.
Publicado: (2021)

Pharmacokinetics/Pharmacodynamics and tolerability of cefiderocol in the clinical setting
por: Perea, José Ramón Azanza, et al.
Publicado: (2022)

Cefiderocol
por: Soriano, María Cruz, et al.
Publicado: (2022)

Pustular lesions and itching in a couple of young migrants
por: Pipitò, Luca, et al.
Publicado: (2022)

Cefiderocol-Based Combination Therapy for “Difficult-to-Treat” Gram-Negative Severe Infections: Real-Life Case Series and Future Perspectives
por: Bavaro, Davide Fiore, et al.
Publicado: (2021)

A severe case of Israeli spotted fever with pleural effusion in Italy
por: Guccione, Cristoforo, et al.
Publicado: (2021)

The Use of Intravenous Fosfomycin in Clinical Practice: A 5-Year Retrospective Study in a Tertiary Hospital in Italy
por: Anastasia, Antonio, et al.
Publicado: (2023)

Monkeypox proctitis treated with doxycycline in an HIV MSM returning to Italy from France
por: Pipitò, Luca, et al.
Publicado: (2022)

Postpartum listeria meningitis
por: Colomba, Claudia, et al.
Publicado: (2020)

Cefiderocol for Carbapenem-Resistant Bacteria: Handle with Care! A Review of the Real-World Evidence
por: Sansone, Pasquale, et al.
Publicado: (2022)

Disc Diffusion and ComASP(®) Cefiderocol Microdilution Panel to Overcome the Challenge of Cefiderocol Susceptibility Testing in Clinical Laboratory Routine
por: Bianco, Gabriele, et al.
Publicado: (2023)

Clinical experience of cefiderocol
por: Fariñas, María Carmen
Publicado: (2022)

Mechanism of action of cefiderocol
por: Soriano, Alex, et al.
Publicado: (2022)

Cefiderocol. Summary and conclusions
por: Mensa, José, et al.
Publicado: (2022)

Antibacterial spectrum of cefiderocol
por: Cordero, Desirée Gijón, et al.
Publicado: (2022)

Clinical Pharmacokinetics and Pharmacodynamics of Cefiderocol
por: Bilal, Muhammad, et al.
Publicado: (2021)

The role of cefiderocol in clinical practice
por: Maseda, Emilio, et al.
Publicado: (2022)

In Vitro Activity of Cefiderocol on Multiresistant Bacterial Strains and Genomic Analysis of Two Cefiderocol Resistant Strains
por: Padovani, Michela, et al.
Publicado: (2023)

Real-world clinical outcomes of cefiderocol therapy in the Veterans Health Administration, 2019–2022
por: Amenta, Eva, et al.
Publicado: (2023)

Real-life experience with compassionate use of cefiderocol for difficult-to-treat resistant Pseudomonas aeruginosa (DTR-P) infections
por: Meschiari, Marianna, et al.
Publicado: (2021)

Successful Treatment of Persistent Stenotrophomonas maltophilia Bacteremia With Cefiderocol in an Infant
por: Hsu, Alice J, et al.
Publicado: (2023)

Staphylococcus aureus and Coagulase-Negative Staphylococci from Bloodstream Infections: Frequency of Occurrence and Antimicrobial Resistance, 2018–2021
por: Serra, Nicola, et al.
Publicado: (2023)

2752. Outcomes of Patients with Stenotrophomonas maltophilia infections treated with Cefiderocol in PROVE (Retrospective Cefiderocol Chart Review) Study
por: Marcella, Stephen, et al.
Publicado: (2023)

Real-Life Data on the Effectiveness and Safety of Cefiderocol in Severely Infected Patients: A Case Series
por: Fendian, Ángel Marcos, et al.
Publicado: (2023)

2811. Real-World Experience Utilizing Cefiderocol for Serious Multidrug Resistant Gram-Negative Infections
por: Teran, Nicholas S, et al.
Publicado: (2023)

Evolution of β-lactamase-mediated cefiderocol resistance
por: Fröhlich, Christopher, et al.
Publicado: (2022)

Acinetobacter baumannii and Cefiderocol, between Cidality and Adaptability
por: Stracquadanio, Stefano, et al.
Publicado: (2022)

Exploring Cefiderocol Resistance Mechanisms in Burkholderia pseudomallei
por: Hall, Carina M., et al.
Publicado: (2023)

Intravenous Fosfomycin: A Potential Good Partner for Cefiderocol. Clinical Experience and Considerations
por: Marino, Andrea, et al.
Publicado: (2022)

Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance
por: König, Christina, et al.
Publicado: (2021)

666. Outcomes Using Cefiderocol for the Treatment of Acinetobacter baumannii Infections from the PROVE (Real-World Evidence) Study
por: Marcella, Stephen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7uac6rv8754p4rq3alqv2o21m4